| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | N-acylsphingosine amidohydrolase activity | 4.87e-05 | 7 | 31 | 2 | GO:0017040 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 5.39e-04 | 103 | 31 | 3 | GO:0004553 | |
| GeneOntologyMolecularFunction | sialic acid binding | 6.84e-04 | 25 | 31 | 2 | GO:0033691 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.42e-03 | 144 | 31 | 3 | GO:0016798 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 1.48e-03 | 146 | 31 | 3 | GO:0016810 | |
| GeneOntologyMolecularFunction | zinc ion binding | 2.19e-03 | 891 | 31 | 6 | GO:0008270 | |
| Domain | Ceramidse_alk_C | 2.33e-06 | 2 | 29 | 2 | PF17048 | |
| Domain | Ceramidase_alk | 2.33e-06 | 2 | 29 | 2 | IPR006823 | |
| Domain | NEUT/ALK_ceramidase_C | 2.33e-06 | 2 | 29 | 2 | IPR031331 | |
| Domain | Butyrophylin | 1.72e-04 | 70 | 29 | 3 | IPR003879 | |
| Domain | SPRY | 3.27e-04 | 87 | 29 | 3 | SM00449 | |
| Domain | Fibrinogen_CS | 3.92e-04 | 19 | 29 | 2 | IPR020837 | |
| Domain | SPRY | 4.10e-04 | 94 | 29 | 3 | PF00622 | |
| Domain | SPRY_dom | 4.10e-04 | 94 | 29 | 3 | IPR003877 | |
| Domain | B30.2/SPRY | 4.23e-04 | 95 | 29 | 3 | IPR001870 | |
| Domain | B302_SPRY | 4.23e-04 | 95 | 29 | 3 | PS50188 | |
| Domain | - | 6.29e-04 | 24 | 29 | 2 | 4.10.530.10 | |
| Domain | Fibrinogen_a/b/g_C_2 | 6.29e-04 | 24 | 29 | 2 | IPR014715 | |
| Domain | C2H2_Znf_fam | 6.29e-04 | 24 | 29 | 2 | IPR027775 | |
| Domain | Fibrinogen_C | 7.98e-04 | 27 | 29 | 2 | PF00147 | |
| Domain | FBG | 9.21e-04 | 29 | 29 | 2 | SM00186 | |
| Domain | - | 9.86e-04 | 30 | 29 | 2 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 9.86e-04 | 30 | 29 | 2 | IPR014716 | |
| Domain | Fibrinogen_a/b/g_C_dom | 1.12e-03 | 32 | 29 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 1.12e-03 | 32 | 29 | 2 | PS51406 | |
| Domain | FIBRINOGEN_C_1 | 1.12e-03 | 32 | 29 | 2 | PS00514 | |
| Domain | C2-set_2 | 1.84e-03 | 41 | 29 | 2 | PF08205 | |
| Domain | CD80_C2-set | 1.84e-03 | 41 | 29 | 2 | IPR013162 | |
| Domain | SCAN | 3.40e-03 | 56 | 29 | 2 | SM00431 | |
| Domain | SCAN_BOX | 3.65e-03 | 58 | 29 | 2 | PS50804 | |
| Domain | SCAN | 3.65e-03 | 58 | 29 | 2 | PF02023 | |
| Domain | SCAN_dom | 3.65e-03 | 58 | 29 | 2 | IPR003309 | |
| Domain | Retrov_capsid_C | 3.77e-03 | 59 | 29 | 2 | IPR008916 | |
| Domain | ConA-like_dom | 4.64e-03 | 219 | 29 | 3 | IPR013320 | |
| Domain | BBOX | 5.12e-03 | 69 | 29 | 2 | SM00336 | |
| Domain | - | 5.41e-03 | 71 | 29 | 2 | 4.10.45.10 | |
| Domain | ZF_BBOX | 6.82e-03 | 80 | 29 | 2 | PS50119 | |
| Domain | Znf_B-box | 6.99e-03 | 81 | 29 | 2 | IPR000315 | |
| Pubmed | 3.19e-07 | 15 | 32 | 3 | 19703589 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 10652340 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 16380386 | ||
| Pubmed | Neutral ceramidase gene: role in regulating ceramide-induced apoptosis. | 8.20e-07 | 2 | 32 | 2 | 14557071 | |
| Pubmed | Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury. | 8.20e-07 | 2 | 32 | 2 | 35151662 | |
| Pubmed | Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease. | 8.20e-07 | 2 | 32 | 2 | 22940715 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 24659784 | ||
| Pubmed | A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer's disease. | 8.20e-07 | 2 | 32 | 2 | 17334805 | |
| Pubmed | Loss of neutral ceramidase protects cells from nutrient- and energy -deprivation-induced cell death. | 8.20e-07 | 2 | 32 | 2 | 26747710 | |
| Pubmed | Genomic structure and promoter analysis of the mouse neutral ceramidase gene. | 8.20e-07 | 2 | 32 | 2 | 12435403 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 10753931 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 37944753 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 11328816 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 35354041 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 21613224 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 16126722 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 27609772 | ||
| Pubmed | Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation. | 8.20e-07 | 2 | 32 | 2 | 19345744 | |
| Pubmed | Lactosylceramide contributes to mitochondrial dysfunction in diabetes. | 8.20e-07 | 2 | 32 | 2 | 26900161 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 18955860 | ||
| Pubmed | The molecular circuitry regulating the switch between iron deficiency and overload in mice. | 2.46e-06 | 3 | 32 | 2 | 16418170 | |
| Pubmed | Neutral ceramidase secreted by endothelial cells is released in part associated with caveolin-1. | 2.46e-06 | 3 | 32 | 2 | 12921776 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 38302493 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 20803549 | ||
| Pubmed | Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis. | 4.92e-06 | 4 | 32 | 2 | 33547170 | |
| Pubmed | Localization of neutral ceramidase in caveolin-enriched light membranes of murine endothelial cells. | 4.92e-06 | 4 | 32 | 2 | 11591392 | |
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 1.80e-05 | 55 | 32 | 3 | 19468303 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 1.70e-04 | 21 | 32 | 2 | 21337463 | |
| Pubmed | Dissecting Wnt/beta-catenin signaling during gastrulation using RNA interference in mouse embryos. | 2.43e-04 | 25 | 32 | 2 | 15857914 | |
| Pubmed | 2.81e-04 | 1442 | 32 | 7 | 35575683 | ||
| Pubmed | 2.84e-04 | 27 | 32 | 2 | 23096701 | ||
| Pubmed | 8.46e-04 | 202 | 32 | 3 | 24639526 | ||
| Cytoband | 16p12.1 | 1.40e-04 | 25 | 32 | 2 | 16p12.1 | |
| Cytoband | 2q11.1 | 1.76e-04 | 28 | 32 | 2 | 2q11.1 | |
| Cytoband | 1p34 | 2.30e-04 | 32 | 32 | 2 | 1p34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p12 | 2.84e-03 | 113 | 32 | 2 | chr12p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q11 | 5.13e-03 | 153 | 32 | 2 | chr2q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q11 | 7.63e-03 | 188 | 32 | 2 | chr10q11 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 2.01e-04 | 95 | 22 | 3 | 59 | |
| GeneFamily | Fibrinogen C domain containing | 4.17e-04 | 25 | 22 | 2 | 554 | |
| GeneFamily | Ring finger proteins | 4.33e-03 | 275 | 22 | 3 | 58 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 8.53e-03 | 115 | 22 | 2 | 769 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.66e-02 | 163 | 22 | 2 | 590 | |
| ToppCell | remission-unassigned|World / disease stage, cell group and cell class | 4.52e-06 | 155 | 32 | 4 | d81bec894381e3e2d6249a567e8108b8423e5c54 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.16e-06 | 180 | 32 | 4 | a499548391e6833b78f6e920f8e32a755814a9da | |
| ToppCell | Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.89e-05 | 83 | 32 | 3 | 4017af9a4804a06d0f2cd0f285ebf1b582b751de | |
| ToppCell | Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Car4_(Mural.Rgs5Acta2.Car4)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.89e-05 | 83 | 32 | 3 | 59fce941d45f9763a8584f3fd5b7c0738de9f592 | |
| ToppCell | Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Car4_(Mural.Rgs5Acta2.Car4)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.89e-05 | 83 | 32 | 3 | ebabce70dc01fdeda7fccebc2c4a0b686cda580f | |
| Disease | major depressive disorder, COVID-19 | 2.99e-04 | 26 | 29 | 2 | MONDO_0002009, MONDO_0100096 | |
| Disease | rheumatoid arthritis, COVID-19 | 1.81e-03 | 64 | 29 | 2 | EFO_0000685, MONDO_0100096 | |
| Disease | autism spectrum disorder, schizophrenia | 3.98e-03 | 327 | 29 | 3 | EFO_0003756, MONDO_0005090 | |
| Disease | cerebrospinal fluid biomarker measurement | 4.02e-03 | 96 | 29 | 2 | EFO_0006794 | |
| Disease | risk-taking behaviour | 6.33e-03 | 764 | 29 | 4 | EFO_0008579 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WEDVWLKEGFAHYFE | 456 | Q9UKU6 | |
| FWAYAGIHEWVFGQV | 86 | O00574 | |
| NDASWETRFYWHKGL | 96 | P0C7U1 | |
| LALAHKWWDEQGVYA | 101 | Q9NZJ6 | |
| AATVGAAAWWFLYAE | 846 | O14983 | |
| AAWHKHGWEELVYYT | 251 | O75323 | |
| WLSVWIKAYAFVHTG | 201 | Q9UJX3 | |
| WWLVAFAHGDIYAYM | 91 | Q15842 | |
| NDASWETRFYWHKGL | 711 | Q9NR71 | |
| AWFDEAKFGVFIHWG | 51 | P04066 | |
| AEKFQGAWWYADCHA | 271 | O00602 | |
| AHDWGALLAWHFSIY | 171 | Q9H6B9 | |
| WYAHKSLGDGIFWIQ | 6 | Q68D91 | |
| SHFFWGLWALIQAKY | 406 | Q9HBU6 | |
| KHGALFWDLAQLFWD | 86 | A0A1B0GTK4 | |
| VLGWESFASGKHYWE | 371 | Q8WVV5 | |
| GLAVDWVHKHIYWTD | 501 | Q14114 | |
| AWGARVFSFGKHYWE | 326 | Q96BQ3 | |
| TEKNWFHYAARIWDG | 491 | Q9H0W8 | |
| VHGYWFRAGNDISWK | 61 | Q9Y286 | |
| GWAHLRWGVFDEYNV | 156 | Q9Y6N3 | |
| YHHDWFIFKEWCEVG | 551 | P51790 | |
| QGVSWYHWKGFEFSV | 4211 | P22105 | |
| AGYHVWLWAVEAFAK | 956 | Q8TEQ6 | |
| IAFLWKHWDALFSYV | 631 | O94876 | |
| AADNHRWKYVNGEWV | 96 | O15178 | |
| WHWALYLIEKGEYEA | 256 | Q5R3I4 | |
| WGLEDEKIAGVHWSY | 331 | Q63HK3 | |
| AWGARVFSFGKHYWE | 326 | A6NCK2 | |
| DLMYAKWAFVHWYVG | 396 | Q6PEY2 | |
| WSFEDEKVAGVHWGY | 236 | Q8IWY8 | |
| WCAQAFTSGKHYWEV | 331 | A6NLI5 |